Literature DB >> 19198703

Erectile dysfunction and its relationship with cardiovascular risk factors and disease.

Eshiobo Irekpita1, Taofik A Salami.   

Abstract

Penile erection is a complex hydraulic process, in which the cardiovascular system (CVS) plays a central role. Erectile dysfunction (ED) is the inability to achieve, and/or maintain penile erection sufficient for satisfactory sexual intercourse, and was previously regarded as part of aging. It is associated with certain diseases and life style habits with a cause-effect relationship, including diabetes mellitus, hypertension, dyslipidemia, and cigarette smoking. Through atherosclerotic narrowing, these diseases may cause coronary artery disease (CAD) and ED, with ED featuring earlier due to the small size of the pudendal artery. The common denominator in ED and CAD is endothelial dysfunction. Men presenting with ED should be evaluated for CVS risk factors, as there is mounting evidence that ED is a sentinel event for CAD. The treatment of men with CAD and concomitant ED should be individualized, and undertaken jointly by the managing physician and urologist.

Entities:  

Mesh:

Year:  2009        PMID: 19198703

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  3 in total

1.  Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction.

Authors:  Hicham Labazi; Brandi M Wynne; Rita Tostes; R Clinton Webb
Journal:  J Sex Med       Date:  2013-07-24       Impact factor: 3.802

2.  Sexual Dysfunction before and after Cardiac Rehabilitation.

Authors:  Jörg Schumann; Michael J Zellweger; Marcello Di Valentino; Simone Piazzalonga; Andreas Hoffmann
Journal:  Rehabil Res Pract       Date:  2010-07-07

3.  Evaluation of the Causes of Erectile Dysfunction in Patients Undergoing Penile Doppler Ultrasonography in Pakistan.

Authors:  Usman Khanzada; Sohail Ahmed Khan; Munawar Hussain; Hatem Adel; Kamran Masood; Syed Omair Adil; Murli Manohar
Journal:  World J Mens Health       Date:  2017-04       Impact factor: 5.400

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.